Putative partial agonist 1-aminocyclopropanecarboxylic acid acts concurrently as a glycine-site agonist and a glutamate-site antagonist at N- methyl-D-aspartate receptors

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1207-1218

  Nahum Levy, Rinat ^a   Fossom, Linda H ^b,c   Skolnick, Phil ^b,d   Benveniste, Morris ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PARTIAL AGONIST;

ANIMAL CELL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG SCREENING; HIPPOCAMPUS; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

EID: 0032732121     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.6.1207     Document Type: Article

References (37)

1. Benveniste H, Drejer J, Schousboe A and Diemer NH (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369-1374.
2. Benveniste M, Clements JD, Vyklicky L Jr and Mayer ML (1990) A kinetic analysis of the modulation of N-methyl-D-aspartic acid receptors by glycine in mouse cultured hippocampal neurones. J Physiol (Lond) 428:333-357.
3. Benveniste M and Mayer ML (1991) Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors: Two binding sites each for glutamate and glycine. Biophys J 59:560-573.
4. Bigge CF and Boxer PA (1994) Neuronal cell death and strategies for neuroprotection. Ann Rep Med Chem 29:13-21.
5. Boje KM, Wong G and Skolnick P (1993) Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures. Brain Res 603:207-214.
6. Cherkofsky SC (1995) 1-Aminocyclopropanecarboxylic acid: Mouse to man interspecies pharmacokinetic comparisons and allometric relationships. J Pharm Sci 84: 1231-1235.
7. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276.
8. Clements JD, Lester RAJ, Tong G, Jahr CE and Westbrook GL (1992) The time course of glutamate in the synaptic cleft. Science (Wash DC) 258:1497-1150.
9. Clements JD and Westbrook GL (1991) Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-D-aspartate receptor. Neuron 7:605-613.
10. Fossom LH, Basile AS and Skolnick P (1995a) Sustained exposure to 1-aminocyclopropanecarboxylic acid, a glycine partial agonist, alters N-methyl-D-aspartate receptor function and subunit composition. Mol Pharmacol 48:981-987.
11. Fossom LH, Von Lubitz DKJE, Lin RC-S and Skolnick P (1995b) Neuroprotective actions of 1-aminocyclopropanecarboxylic acid, a partial agonist at strychnine-insensitive glycine sites. Neurol Res 17:265-269.
12. Gallo V, Ciotti MT, Coletti A, Aloisi F and Levi G (1982) Selective release of glutamate from cerebellar granule cells differentiating in culture. Proc Natl Acad Sci USA 79:7919-7923.
13. Garthwaite G and Garthwaite J (1986) Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration. Neurosci Lett 66:193-198.
14. Globus MY-T, Busto R, Martinez E, Valdés I, Dietrich WD and Ginzberg MD (1991) Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and γ-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem 57:470-478.
15. Hartley DM and Choi DW (1989) Delayed rescue of N-methyl-D-aspartate receptor mediated neuronal injury in cortical culture. J Pharmacol Exl Ther 250:752-758.
16. Johnson JW and Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (Lond) 325:529-531.
17. Kleckner NW and Dingledine R (1988) Requirement for glycine inactivation of NMDA-receptors expressed in Xenopus oocytes. Science (Wash DC) 241:835-837.
18. Logusch EW (1986) Facile synthesis of D,L-phosphinothricin from methyl 4-bromo-2-phthalimidobutyrate. Tetrahed Lett 27:5935-5939.
19. Long JB and Skolnick P (1994) 1-Aminocyclopropanecarboxylic acid protects against dynorphin A-induced spinal injury. Eur J Pharmacol 261:295-301.
20. Maccecchini ML (1995) Partial agonism and neuroprotection, in Ischemic Stroke: Recent Advances in Understanding and Therapy (Grotta J, Miller LP and Buchan AM eds) pp 140-168, International Business Communications, Soutbboro.
21. Mayer ML and Westbrook GL (1987) Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (Lond) 394:501-527.
22. McBain CJ, Kleckner NW, Wyrick S and Dingledine R (1989) Structural requirements for activation of the glycine co-agonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Mol Pharmacol 36:556-565.
23. Meldrum B (1994) Neuroprotection by NMDA and non-NMDA glutamate antagonists, in Direct and Allosteric Control of Glutamate Receptors (Palfreyman MG, Reynolds IJ and Skolnick P eds) pp 127-138, CRC Press, Boca Raton.
24. Muir KW, Grosset DG, Gamzu E and Lees KR (1994) Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers. Br J Clin Pharmacol 38:33-38.
25. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S and Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34:1239-1258.
26. Patneau DK and Mayer ML (1990) Structure-activity relationships for amino acid transmitter candidates acting a N-methyl-D-aspartate and quisqualate receptors. J Neurosci 10:2385-2399.
27. Priestley T and Kemp JA (1994) Kinetic study of the interactions between the glutamate and glycine recognition sites on the N-methyl-D-aspartic acid receptor complex. Mol Pharmacol 46:1191-1196.
28. Rockstroh S, Emre M, Tarral A and Pokorny R (1996) Effects of the novel NMDA-receptor antagonist SDZ EAA 494 on memory and attention in humans. Psychopharmacology 124:261-266.
29. Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: Channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14:325-331.
30. Schneggenburger R, Zhou Z, Konnerth A and Neher E (1993) Fractional contribution of calcium to the cation current through glutamate receptor channels. Neuron 11:133-143.
31. Schubert H, Rack M and Mühlstädt M (1990) Eine vereinfachte synthese der 1-aminocyclopropan-1-carbonsäure. J f Prakt Chemie 332:812-814.
32. Skolnick P, Marvizon J, Jackson B, Monn J. Rice K and Lewin A (1989) Blockade of N-methyl-D-aspartate induced convulsions by 1-aminocyclopropanecarboxylates. Life Sci 45:1647-1655.
33. Sveinbjornsdottir S, Sander JWAS, Upton D, Thompson PJ, Patsalos PN, Hirt D, Emre M, Lowe D and Duncan JS (1993) The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res 16:165-174.
34. Szatkowski M and Attwell D (1994) Triggering and execution of neuronal death in brain ischaemia: Two phases of glutamate release by different mechanisms. Trends Neurosci 17:359-365.
35. Vaidyanathan G and Wilson JW (1989) Decarboxylation of 1-aminocyclopropanecarboxylic acid and its derivatives. J Org Chem 64:1810-1815.
36. Villarroel A, Regalado MP and Lerma J (1998) Glycine-independent NMDA receptor desensitization: Localization of structural determinants. Neuron 20:329-339.
37. Watson GB and Lanthorn TH (1990) Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site. Neuropharmacology 29:727-730.